CD, E., J, S., SW, A., DA, B., PM, H., MA, M., & JR, S. (2023). APOE ε4's impact on response to amyloid therapies in early symptomatic Alzheimer's disease: Analyses from multiple clinical trials. Alzheimer's & dementia : the journal of the Alzheimer's Association, 19(12), 5407. https://doi.org/10.1002/alz.13128
Chicago Style (17th ed.) CitationCD, Evans, Sparks J, Andersen SW, Brooks DA, Hauck PM, Mintun MA, and Sims JR. "APOE ε4's Impact on Response to Amyloid Therapies in Early Symptomatic Alzheimer's Disease: Analyses from Multiple Clinical Trials." Alzheimer's & Dementia : The Journal of the Alzheimer's Association 19, no. 12 (2023): 5407. https://doi.org/10.1002/alz.13128.
MLA (9th ed.) CitationCD, Evans, et al. "APOE ε4's Impact on Response to Amyloid Therapies in Early Symptomatic Alzheimer's Disease: Analyses from Multiple Clinical Trials." Alzheimer's & Dementia : The Journal of the Alzheimer's Association, vol. 19, no. 12, 2023, p. 5407, https://doi.org/10.1002/alz.13128.